secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001493152-25-004298
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa closes $5M public offering; Series A/B warrants at $0.65 exercise price
--------------------------------------------------------------------------------

- Gross proceeds of $5.0M from offering closed Jan 29, 2025; net proceeds for general corporate purposes.
- Offered 8,050,672 shares (or pre-funded warrants) at combined price of $0.615 (institutions) / $0.7975 (CEO/board) with Series A and B warrants.
- Series A warrants exercisable at $0.65 for 5 years, Series B at $0.65 for 18 months, both subject to stockholder approval.
- CEO and certain board members participated alongside a healthcare-focused institutional investor; A.G.P. acted as sole placement agent.
- Company to seek stockholder approval within 90 days for warrant share issuance; otherwise will call meetings every 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225004298/0001493152-25-004298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225004298/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer